Ryan Murray
Impact in
- Oncology top 5%
- Viral-associated cancers and disorders
-
- Lymphoma Diagnosis and Treatment
Papers in
-
- interferon and immune responses 1
- Co-authors
- F Wang (1 shared paper)Clare E. Sample (1 shared paper)Martin Rowe (1 shared paper)Alan B. Rickinson (1 shared paper)C D Gregory (1 shared paper)Elliott Kieff (1 shared paper)D Liebowitz (1 shared paper)Hidemi S. Yamamoto (2 shared papers)
- Journals
- PLoS ONE (2 papers)Journal of Virology (1 paper)Scientific Reports (1 paper)The Journal of Immunology (1 paper)Science Translational Medicine (1 paper)
- Partner nations
- United StatesAustraliaIndia
In The Last Decade
Ryan Murray
10 papers receiving 766 citations
Ryan Murray's Hit Papers
Peers
Comparison fields: 5 of 80
- Oncology 498
- Pathology and Forensic Medicine 271
- Immunology 227
- Microbiology 66
- Infectious Diseases 143
Countries citing papers authored by Ryan Murray
This map shows the geographic impact of Ryan Murray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryan Murray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryan Murray more than expected).
Fields of papers citing papers by Ryan Murray
This network shows the impact of papers produced by Ryan Murray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryan Murray. The network helps show where Ryan Murray may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryan Murray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23 Hit paper breakdown → | 1990 | 496 |
| 2 | 2012 | 111 | |
| 3 | 2014 | 42 | |
| 4 | 2014 | 40 | |
| 5 | 2014 | 28 | |
| 6 | 1991 | 17 | |
| 7 | 1988 | 15 | |
| 8 | 2015 | 14 | |
| 9 | 2016 | 12 | |
| 10 | 2022 | 1 |
About Ryan Murray
Ryan Murray is a scholar working on Epidemiology, Immunology, Oncology, Surgery and Genetics, having authored 10 papers that have together received 776 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (2 papers), Tissue Engineering and Regenerative Medicine (2 papers), Cancer Cells and Metastasis (2 papers), Reproductive tract infections research (2 papers), 3D Printing in Biomedical Research (2 papers), interferon and immune responses (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Emergency and Acute Care Studies (1 paper). The work is most often cited by research in Oncology (498 citations), Pathology and Forensic Medicine (271 citations), Immunology (227 citations), Microbiology (66 citations) and Infectious Diseases (143 citations). Ryan Murray has collaborated with scholars based in United States, Australia and India. Frequent co-authors include F Wang, Clare E. Sample, Martin Rowe, Alan B. Rickinson, C D Gregory, Elliott Kieff, D Liebowitz, Hidemi S. Yamamoto, Raina N. Fichorova and Biju Parekkadan. Their work appears in journals such as PLoS ONE, Journal of Virology, Scientific Reports, The Journal of Immunology and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.